Skip to content

Safety and Efficacy of the Sterile Single-use Circular Stapling Device CIRCCURER II (Jiangxi Langhe Medical Instrument Co., Ltd., Guangzhou, China)

Evaluation of the Safety and Efficacy of the Sterile Single-use Circular Stapling Device CIRCCURER II (Jiangxi Langhe Medical Instrument Co., Ltd., Guangzhou, China) in Adult Patients Suffering From Pathologic Foreskin (Phimosis, Stenosis, Redundant Prepuce): A Prospective Randomised Comparative Clinical Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04902898
Acronym
CiCi-2021
Enrollment
100
Registered
2021-05-26
Start date
2021-05-11
Completion date
2023-10-31
Last updated
2022-01-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Foreskin; Tightness, Phimosis, Redundant Prepuce

Brief summary

Evaluation of the safety and efficacy of the sterile single-use circular stapling device CIRCCURER II (Jiangxi Langhe Medical Instrument Co., Ltd., Guangzhou, China) in comparison with circumcision in adults patients with pathological foreskin (phimosis, stenosis, redundant prepuce)

Interventions

DEVICECircumcision in adults using sterile single-use circular stapling device

Circumcision in adults using sterile single-use circular stapling device CIRCCURER II (Jiangxi Langhe Medical Instrument Co., Ltd., Guangzhou, China)

PROCEDURECircumcision in adults

Circumcision in adults

Sponsors

University of Thessaly
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
16 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

:phimosis, stenosis of foreskin, redundant prepuce

Exclusion criteria

: active inflammation of foreskin

Design outcomes

Primary

MeasureTime frameDescription
Postoperative hematomaFirst postoperative dayMeasurement defined as follows: mild=1, moderate=2 and large=3, according to the surgeon's estimation
BleedingIntraoperativelyNumber of gauzes used intraoperatively
Postoperative oedemaTwenty first postoperative dayMeasurement defined as follows: mild=1, moderate=2 and large=3, according to the surgeon's estimation
Duration of procedureIntraoperative (Measurement begins at the time of the beginning of the sterilisation of the surgical field and ends at the time of the completion of the bandeage of the wound)Minutes

Secondary

MeasureTime frameDescription
Aesthetic resultNineteenth postoperative dayVisual analogue scale from 0 to 10, as follows: 0 - 5 = unsatisfactory, 6 - 7 = moderately satisfactory, 8 - 9 = very satisfactory, 10 = excellent, according to the patient's estimation
Postoperative oedemaFirst postoperative dayMeasurement defined as follows: mild=1, moderate=2 and large=3, according to the surgeon's estimation

Other

MeasureTime frameDescription
Pain feelingIntraoperativelyVisual analogue scale from 0 to 10, as follows: 0 = no pain, 1-3 = mild pain, 4-6 = moderate pain, 7-9 = very severe pain and 10 = worst possible pain, according to the patient's estimation
Used suturesIntraoperativelyAbsolute number of used sutures
AnaesthesiaImmediately preoperativelyQuantity of applied lidocaine hydrochloride 2% w/v in milliliters

Countries

Greece

Contacts

Primary ContactVasileios Tzortzis, Professor
urologydpt.uth@gmail.com00302413502811
Backup ContactLampros Mitrakas, Consultant
lamprosmit@gmail.com00302413501325

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026